Breast cancer treatment can be improved with biomarkers for early detection and
individualized therapy. A set of 86 microRNAs (miRNAs) were identified to separate breast …

SLC25A26 is the only known human mitochondrial S-adenosylmethionine carrier encoding
gene. Recent studies have shown that SLC25A26 is abnormally expressed in some …

There are currently no effective biomarkers for prognosis and optimal treatment selection to
improve non-small cell lung cancer (NSCLC) survival outcomes. This study further validated …

Simple Summary Tumor cells can evade destruction via immune cells by expressing
coinhibitory membrane molecules, which can suppress tumor-specific T cells. Immune …

Simple Summary This study identified a set of 73 microRNAs (miRNAs) that can accurately
detect lung cancer tumors from normal lung tissues. Based on the consistent expression …

There is an unmet clinical need to identify patients with early-stage non-small cell lung
cancer (NSCLC) who are likely to develop recurrence and to predict their therapeutic …

Simple Summary This study presents novel insights on dysregulated B cell proliferation
networks in non-small cell lung cancer (NSCLC). Within this network, a nine-gene signature …

There are insufficient accurate biomarkers and effective therapeutic targets in current cancer
treatment. Multi-omics regulatory networks in patient bulk tumors and single cells can shed …

There are currently no accurate biomarkers for optimal treatment selection in early-stage
non-small cell lung cancer (NSCLC). Novel therapeutic targets are needed to improve …

There is currently no gene expression assay that can assess if premalignant lesions will
develop into invasive breast cancer. This study sought to identify biomarkers for selecting …